Oncologia

2017

• Antonello, ZA; Hsu, N; Bhasin, M; Roti, G; Joshi, M; Van Hummelen, P; Ye, E; Lo, AS; Karumanchi, SA; Bryke, CR; Nucera, C (2017) Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF(V600E) ONCOTARGET 8(49):84743-84760 IF₂₀₁₆=5.168 [Article]
• Aprile, G; Negri, FV; Giuliani, F; De Carlo, E; Melisi, D; Simionato, F; Silvestris, N; Brunetti, O; Leone, F; Marino, D; Santini, D; Dell’Aquila, E; Zeppola, T; Puzzoni, M; Scartozzi, M (2017) Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 115():1-12 IF₂₀₁₆=4.971 [Review]
• Aversa, F; Busca, A; Candoni, A; Cesaro, S; Girmenia, C; Luppi, M; Nosari, AM; Pagano, L; Romani, L; Rossi, G; Venditti, A; Novelli, A (2017)  Liposomal amphotericin B (AmBisome (R)) at beginning of its third decade of clinical use JOURNAL OF CHEMOTHERAPY 29( 3):131-143 IF₂₀₁₆=1.577 [Review]
• Bersanelli, M; Bini, P; Rabaiotti, E; Facchinetti, F; De Filippo, M; Bortesi, B; Buti, S; Tiseo, M (2017)  Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder TUMORI 103( 1):66-71 IF₂₀₁₆=1.233 [Article]
• Bersanelli, M; Buti, S (2017) Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 9(10):627-636 IF₂₀₁₆=6.294 [Review]
• Bersanelli, M; Gelsomino, F; Buti, S; Fiorentino, M; Tiseo, M (2017)  Plasma genotyping for EGFR T790M in non-small cell lung cancer: ready for clinical practice? TRANSLATIONAL CANCER RESEARCH 6( ):0-S64 [Editorial Material]
• Bersanelli, M; Leonetti, A; Buti, S; Michiara, M (2017)  Finding NEMO in NRAS-mutant melanoma: a step towards a sequential strategy? LANCET ONCOLOGY 18( 6):0-E298 [Letter]
• Bonelli, MA; Digiacomo, G; Fumarola, C; Alfieri, R; Quainia, F; Falco, A; Madeddu, D; La Monica, S; Cretella, D; Ravelli, A; Ulivi, P; Tebaldi, M; Calistri, D; Delmonte, A; Ampollini, L; Carbognani, P; Tiseo, M; Cavazzoni, A; Petronini, PG (2017) Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells NEOPLASIA 19(8):637-648 IF₂₀₁₆=5.006 [Article]
• Bordi, P; Tiseo, M; Rofi, E; Petrini, I; Restante, G; Danesi, R; Del Re, M (2017) Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment CLINICAL LUNG CANCER 18(6):692-697 IF₂₀₁₆=3.434 [Article]
• Brandes, AA; Franceschi, E; Paccapelo, A; Tallini, G; De Biase, D; Ghimenton, C; Danieli, D; Zunarelli, E; Lanza, G; Silini, EM; Sturiale, C; Volpin, L; Servadei, F; Talacchi, A; Fioravanti, A; Foschini, MP; Bartolini, S; Pession, A; Ermani, M (2017)  Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications ONCOLOGIST 22( 4):432-437 IF₂₀₁₆=4.962 [Article]
• Busca, A; Lessi, F; Verga, L; Candoni, A; Cattaneo, C; Cesaro, S; Dragonetti, G; Delia, M; De Luca, A; Guglielmi, G; Tumbarello, M; Martino, G; Nadali, G; Fanci, R; Picardi, M; Potenza, L; Nosari, A; Aversa, F; Pagano, L (2017) SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy LEUKEMIA & LYMPHOMA 58(12):2859-2864 IF₂₀₁₆=2.755 [Article]
• Buti, S; Bersanelli, M (2017)  Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma? JOURNAL OF CLINICAL ONCOLOGY 35( 16):1858-+ [Letter]
• Buti, S; Bersanelli, M; Maines, F; Facchini, G; Gelsomino, F; Zustovich, F; Santoni, M; Verri, E; De Giorgi, U; Masini, C; Morelli, F; Vitale, MG; Sava, T; Prati, G; Librici, C; Fraccon, AP; Fornarini, G; Maruzzo, M; Leonardi, F; Caffo, O (2017) First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study CLINICAL GENITOURINARY CANCER 15(4):0-0 IF₂₀₁₆=2.535 [Article]
• Buti, S; Puligandla, M; Bersanelli, M; DiPaola, RS; Manola, J; Taguchi, S; Haas, NB (2017) Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population ANNALS OF ONCOLOGY 28(11):2747-2753 IF₂₀₁₆=11.855 [Article]
• Campobasso, D; Ferretti, S; Frattini, A (2017) Synchronous bilateral testis cancer: clinical and oncological management WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY 21(1):70-76 IF₂₀₁₆=0 [Article]
• Capasso, R; Nizzoli, R; Tiseo, M; Pedrazzi, G; Brunese, L; Rotondo, A; De Filippo, M (2017)  Extra-pleuric coaxial system for CT-guided percutaneous fine-needle aspiration biopsy (FNAB) of small (<= 20 mm) lung nodules: a novel technique using multiplanar reconstruction (MPR) images MEDICAL ONCOLOGY 34( 2):- IF₂₀₁₆=2.634 [Article]
• Cavazzoni, A; La Monica, S; Alfieri, R; Ravelli, A; Van Der Steen, N; Sciarrillo, R; Madeddu, D; Lagrasta, CAM; Quaini, F; Bonelli, M; Fumarola, C; Cretella, D; Digiacomo, G; Tiseo, M; Peters, GJ; Ardizzoni, A; Petronini, PG; Giovannetti, E (2017) Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN ONCOTARGET 8(32):53068-53083 IF₂₀₁₆=5.168 [Article]
• Cazzaniga, ME; Airoldi, M; Arcangeli, V; Artale, S; Atzori, F; Ballerio, A; Bianchi, GV; Blasi, L; Campidoglio, S; Ciccarese, M; Cursano, MC; Piezzo, M; Fabi, A; Ferrari, L; Ferzi, A; Ficorella, C; Frassoldati, A; Fumagalli, A; Garrone, O; Gebbia, V; Generali, D; La Verde, N; Maur, M; Michelotti, A; Moretti, G; Musolino, A; Palumbo, R; Pistelli, M; Porpiglia, M; Sartori, D; Scavelli, C; Schirone, A; Turletti, A; Valerio, MR; Vici, P; Zambelli, A; Clivio, L; Torri, V (2017) Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR plus ) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study BREAST 35():115-121 IF₂₀₁₆=2.801 [Article]
• Ceresoli, M; Allievi, N; Coccolini, F; Montori, G; Fugazzola, P; Pisano, M; Sartelli, M; Catena, F; Ansaloni, L (2017) Long-term oncologic outcomes of stent as a bridge to surgery versus emergency surgery in malignant left side colonic obstructions: a meta-analysis JOURNAL OF GASTROINTESTINAL ONCOLOGY 8(5):867-876 IF₂₀₁₆=0 [Article]
• Comelli, I; Lippi, G; Campana, V; Servadei, F; Cervellin, G (2017) Clinical presentation and epidemiology of brain tumors firstly diagnosed in adults in the Emergency Department: a 10-year, single center retrospective study ANNALS OF TRANSLATIONAL MEDICINE 5(13):- IF₂₀₁₆=0 [Article]
• Costa, F; Toscani, D; Chillemi, A; Quarona, V; Bolzoni, M; Marchica, V; Vescovini, R; Mancini, C; Martella, E; Campanini, N; Schifano, C; Bonomini, S; Accardi, F; Horenstein, AL; Aversa, F; Malavasi, F; Giuliani, N (2017) Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation ONCOTARGET 8(34):56598-56611 IF₂₀₁₆=5.168 [Article]
• Costa, F; Vescovini, R; Bolzoni, M; Marchica, V; Storti, P; Toscani, D; Accardi, F; Notarfranchi, L; Dalla Palma, B; Manferdini, C; Manni, S; Todaro, G; Lisignoli, G; Piazza, F; Aversa, F; Giuliani, N (2017) Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties ONCOTARGET 8(32):53053-53067 IF₂₀₁₆=5.168 [Article]
• Danese, E; Lippi, G; Buonocore, R; Benati, M; Bovo, C; Bonaguri, C; Salvagno, GL; Brocco, G; Roggenbuck, D; Montagnana, M (2017) Mobile phone radiofrequency exposure has no effect on DNA double strand breaks (DSB) in human lymphocytes ANNALS OF TRANSLATIONAL MEDICINE 5(13):- IF₂₀₁₆=0 [Article]
• Del Re, M; Bordi, P; Petrini, I; Rofi, E; Mazzoni, F; Belluomini, L; Vasile, E; Restante, G; Di Costanzo, F; Falcone, A; Frassoldati, A; van Schaik, RHN; Steendam, CMJ; Chella, A; Tiseo, M; Morganti, R; Danesi, R (2017) Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment ONCOTARGET 8(49):86056-86065 IF₂₀₁₆=5.168 [Article]
• Del Re, M; Tiseo, M; Bordi, P; D’Incecco, A; Camerini, A; Petrini, I; Lucchesi, M; Inno, A; Spada, D; Vasile, E; Citi, V; Malpeli, G; Testa, E; Gori, S; Falcone, A; Amoroso, D; Chella, A; Cappuzzo, F; Ardizzoni, A; Scarpa, A; Danesi, R (2017)  Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA ONCOTARGET 8( 8):13611-13619 IF₂₀₁₆=5.168 [Article]
• Facchinetti, F; Rossi, G; Bria, E; Soria, JC; Besse, B; Minari, R; Friboulet, L; Tiseo, M (2017)  Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition CANCER TREATMENT REVIEWS 55( ):83-95 IF₂₀₁₆=8.589 [Review]
• Facchinetti, F; Tiseo, M (2017) Ceritinib in ROS1-positive non-small cell lung cancer patients: does clinical evidence carry clinical impact? TRANSLATIONAL CANCER RESEARCH 6():0-0 IF₂₀₁₆=1.167 [Editorial Material]
• Ferolla, P; Brizzi, MP; Meyer, T; Mansoor, W; Mazieres, J; Do Cao, C; Lena, H; Berruti, A; Damiano, V; Buikhuisen, W; Gronbaek, H; Lombard-Bohas, C; Grohe, C; Minotti, V; Tiseo, M; De Castro, J; Reed, N; Gislimberti, G; Singh, N; Stankovic, M; Oberg, K; Baudin, E (2017) Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial LANCET ONCOLOGY 18(12):1652-1664 IF₂₀₁₆=33.9 [Article]
• Ferrari, A; Magni, C; Bergamaschi, L; Cecchetto, G; Alaggio, R; Milano, GM; Bertolini, P; Basso, E; Manzitti, C; Di Martino, M; Giurici, N; Melchionda, F; Cecinati, V; Chiaravalli, S; Affinita, MC; Scagnellato, A; Casanova, M; Bisogno, G (2017) Pediatric nonrhabdomyosarcoma soft tissue sarcomas arising at visceral sites PEDIATRIC BLOOD & CANCER 64(9):- IF₂₀₁₆=2.513 [Article]
• Fumarola, C; Cretella, D; La Monica, S; Bonelli, MA; Alfieri, R; Caffarra, C; Quaini, F; Madeddu, D; Falco, A; Cavazzoni, A; Digiacomo, G; Mazzaschi, G; Vivo, V; Barocelli, E; Tiseo, M; Petronini, PG; Ardizzoni, A (2017) Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism ONCOTARGET 8(54):91841-91859 IF₂₀₁₆=5.168 [Article]
• Garattini, SK; Basile, D; Cattaneo, M; Fanotto, V; Ongaro, E; Bonotto, M; Negri, FV (non presente); Berenato, R; Ermacora, P; Cardellino, GG; Giovannoni, M; Pella, N; Scartozzi, M; Antonuzzo, L; Silvestris, N; Fasola, G; Aprile, G (2017)  Molecular classifications of gastric cancers: Novel insights and possible future applications WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY 9( 5):194-208 IF₂₀₁₆= [Article]
• Gelsomino, F; Leonetti, A; Rihawi, K; Sperandi, F; Casolari, L; Melotti, B; Fiorentino, M; Ardizzoni, A (2017) Immune checkpoint inhibition in small cell lung cancer: a key to reach an unmet need? TRANSLATIONAL CANCER RESEARCH 6():0-0 IF₂₀₁₆=1.167 [Editorial Material]
• Gobbini, E; Galetta, D; Tiseo, M; Graziano, P; Rossi, A; Bria, E; Di Maio, M; Rossi, G; Gregorc, V; Riccardi, F; Scotti, V; Ceribelli, A; Buffoni, L; Delmonte, A; Franchina, T; Migliorino, MR; Cortinovis, D; Pisconti, S; Bordi, P; Catino, A; Maiello, E; Arizio, F; Novello, S (2017) Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study LUNG CANCER 111():30-37 IF₂₀₁₆=4.294 [Article]
• Haroche, J; Cohen-Aubart, F; Rollins, BJ; Donadieu, J; Charlotte, F; Idbaih, A; Vaglio, A; Abdel-Wahab, O; Emile, JF; Amoura, Z (2017)  Histiocytoses: emerging neoplasia behind inflammation LANCET ONCOLOGY 18( 2):0-E125 IF₂₀₁₆=33.9 [Review]
• Iacovelli, R; Rocca, MC; Galli, L; De Giorgi, U; Sabbatini, R; Santoni, M; Mosca, A; Fornarini, G; Massari, F; Masini, C; Bersanelli, M; Biasco, E; Lolli, C; Guida, A; Berardi, R; Terrone, C; Pastorino, A; Ardizzoni, A; Pinto, C; Buti, S; Nole, F; Tortora, G (2017) Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 35(9):- IF₂₀₁₆=3.767 [Article]
• Infante, M; Sestini, S; Galeone, C; Marchiano, A; Lutman, FR; Angeli, E; Calareso, G; Pelosi, G; Sozzi, G; Silva, M; Sverzellati, N; Cavuto, S; La Vecchia, C; Santoro, A; Alloisio, M; Pastorino, U (2017) Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials EUROPEAN JOURNAL OF CANCER PREVENTION 26(4):324-329 IF₂₀₁₆=2.556 [Article]
• Kim, DW; Tiseo, M; Ahn, MJ; Reckamp, KL; Hansen, KH; Kim, SW; Huber, RM; West, HL; Groen, HJM; Hochmair, MJ; Leighl, NB; Gettinger, SN; Langer, CJ; Rodriguez, LGPA; Smit, EF; Kim, ES; Reichmann, W; Haluska, FG; Kerstein, D; Camidge, DR (2017) Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial JOURNAL OF CLINICAL ONCOLOGY 35(22):2490-0 IF₂₀₁₆=24.008 [Article]
• La Monica, S; Cretella, D; Bonelli, M; Fumarola, C; Cavazzoni, A; Digiacomo, G; Flammini, L; Barocelli, E; Minari, R; Naldi, N; Petronini, PG; Tiseo, M; Alfieri, R (2017) Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 36():- IF₂₀₁₆=5.189 [Article]
• Lippi, G; Mattiuzzi, C; Cervellin, G; Favaloro, EJ (2017) Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends ANNALS OF TRANSLATIONAL MEDICINE 5(16):- IF₂₀₁₆=0 [Article]
• Marchesini, M; Ogoti, Y; Fiorini, E; Samur, AA; Nezi, L; D’Anca, M; Storti, P; Samur, MK; Ganan-Gomez, I; Fulciniti, MT; Mistry, N; Jiang, S; Bao, N; Marchica, V; Neri, A; Bueso-Ramos, C; Wu, CJ; Zhang, L; Liang, H; Peng, XX; Giuliani, N; Draetta, G; Clise-Dwyer, K; Kantarjian, H; Munshi, N; Orlowski, R; Garcia-Manero, G; DePinho, RA; Colla, S (2017) ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma CANCER CELL 32(1):88-0 IF₂₀₁₆=27.407 [Article]
• Marchiano, AV; Cosentino, M; Di Tolla, G; Greco, FG; Silva, M; Sverzellati, N; Fabbri, A; Tamborini, E; Lo Russo, G; Mariani, L; Lalli, L; Pastorino, U (2017) FNA and CNB in the diagnosis of pulmonary lesions: a single-center experience on 665 patients, comparison between two periods TUMORI 103(4):360-366 IF₂₀₁₆=1.233 [Article]
• Masselli, E; Carubbi, C; Pozzi, G; Martini, S; Aversa, F; Galli, D; Gobbi, G; Mirandola, P; Vitale, M (2017) Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk ANNALS OF TRANSLATIONAL MEDICINE 5(13):- IF₂₀₁₆=0 [Article]
• Merigo, E; Conti, S; Ciociola, T; Fornaini, C; Polonelli, L; Lagori, G; Manfredi, M; Vescovi, P (2017)  Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY 18( ):34-38 IF₂₀₁₆=2.219 [Article]
• Mes, SW; te Beest, D; Poli, T; Rossi, S; Scheckenbach, K; van Wieringen, WN; Brink, A; Bertani, N; Lanfranco, D; Silini, EM; van Diest, PJ; Bloemena, E; Leemans, CR; van de Wiel, MA; Brakenhoff, RH (2017) Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables ONCOTARGET 8(35):59312-59323 IF₂₀₁₆=5.168 [Article]
• Musolino, A; Campone, M; Neven, P; Denduluri, N; Barrios, CH; Cortes, J; Blackwell, K; Soliman, H; Kahan, Z; Bonnefoi, H; Squires, M; Zhang, Y; Deudon, S; Shi, MM; Andre, F (2017)  Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2(-) breast cancer that had progressed during or after prior endocrine therapy BREAST CANCER RESEARCH 19( ):- IF₂₀₁₆=6.345 [Article]
• Oudkerk, M; Devaraj, A; Vliegenthart, R; Henzler, T; Prosch, H; Heussel, CP; Bastarrika, G; Sverzellati, N; Mascalchi, M; Delorme, S; Baldwin, DR; Callister, ME; Becker, N; Heuvelmans, MA; Rzyman, W; Infante, MV; Pastorino, U; Pedersen, JH; Paci, E; Duffy, SW; de Koning, H; Field, JK (2017) European position statement on lung cancer screening LANCET ONCOLOGY 18(12):0-0 IF₂₀₁₆=33.9 [Review]
• Pacchiana, MV; Capelletto, E; Carnio, S; Gridelli, C; Rossi, A; Galetta, D; Montagna, ES; Bordi, P; Ceribelli, A; Cortinovis, D; Scotti, V; Martelli, O; Valmadre, G; Del Conte, A; Miccianza, A; Morena, R; Rosetti, F; Di Maio, M; Ostacoli, L; Novello, S (2017) Patients’ Attitudes and Physicians’ Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey CLINICAL LUNG CANCER 18(4):381-387 IF₂₀₁₆=3.434 [Article]
• Palandri, F; Palumbo, GA; Bonifacio, M; Tiribelli, M; Benevolo, G; Martino, B; Abruzzese, E; D’Adda, M; Polverelli, N; Bergamaschi, M; Tieghi, A; Cavazzini, F; Ibatici, A; Crugnola, M; Bosi, C; Latagliata, R; Di Veroli, A; Scaffidi, L; de Marchi, F; Cerqui, E; Anaclerico, B; De Matteis, G; Spinsanti, M; Sabattini, E; Catani, L; Aversa, F; Di Raimondo, F; Vitolo, U; Lemoli, RM; Fanin, R; Merli, F; Russo, D; Cuneo, A; Reggiani, MLB; Cavo, M; Vianelli, N; Breccia, M (2017) Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis ONCOTARGET 8(45):79073-79086 IF₂₀₁₆=5.168 [Article]
• Passalacqua, R; Lazzarelli, S; Donini, M; Montironi, R; Tambaro, R; De Giorgi, U; Pignata, S; Palumbo, R; Ceresoli, GL; Del Conte, G; Tonini, G; Morelli, F; Nole, F; Panni, S; Rondini, E; Guida, A; Zucali, PA; Doni, L; Lezzi, E; Caminiti, C (2017) Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014) BMC CANCER 17():- IF₂₀₁₆=3.288 [Article]
• Pellegrino, B; Musolino, A; Tiseo, M (2017)  Anti-PD-1-related cryoglobulinemia during treatment with nivolumab in NSCLC patient ANNALS OF ONCOLOGY 28( 6):1405-1406 [Letter]
• Perricone, M; Palandri, F; Ottaviani, E; Angelini, M; Bagli, L; Bellesia, E; Donati, M; Gemmati, D; Zucchini, P; Mancini, S; Marchica, V; Trubini, S; De Matteis, G; Di Zacomo, S; Favarato, M; Fioroni, A; Bolzonella, C; Maccari, G; Navaglia, F; Gatti, D; Toffolatti, L; Orlandi, L; Laloux, V; Manfrini, M; Galieni, P; Giannini, B; Tieghi, A; Barulli, S; Serino, ML; Maccaferri, M; Scortechini, AR; Giuliani, N; Vallisa, D; Bonifacio, M; Accorsi, P; Salbe, C; Fazio, V; Gusella, M; Toffoletti, E; Salvucci, M; Svaldi, M; Gherlinzoni, F; Cassavia, F; Orsini, F; Martinelli, G (2017)  Assessment of the interlaboratory variability and robustness of JAK2(V617F) mutation assays: A study involving a consortium of 19 Italian laboratories ONCOTARGET 8( 20):32608-32617 IF₂₀₁₆=5.168 [Article]
• Proto, C; Lo Russo, G; Corrao, G; Ganzinelli, M; Facchinetti, F; Minari, R; Tiseo, M; Garassino, MC (2017) Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms TUMORI JOURNAL 103(4):325-337 IF₂₀₁₆=1.233 [Review]
• Puliti, D; Bucchi, L; Mancini, S; Paci, E; Baracco, S; Campari, C; Canuti, D; Cirilli, C; Collina, N; Conti, GM; Di Felice, E; Falcini, F; Michiara, M; Negri, R; Ravaioli, A; de’ Bianchi, PS; Serafini, M; Zorzi, M; Caldarella, A; Cataliotti, L; Zappa, M (2017)  Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy EUROPEAN JOURNAL OF CANCER 75( ):109-116 IF₂₀₁₆=6.029 [Article]
• Rossi, G; Jocolle, G; Conti, A; Tiseo, M; Marino, FZ; Donati, G; Franco, R; Bono, F; Barbisan, F; Facchinetti, F (2017) Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives LUNG CANCER-TARGETS AND THERAPY 8():45-55 IF₂₀₁₆=0 [Review]
• Rugo, HS; Tredan, O; Ro, J; Morales, SM; Campone, M; Musolino, A; Afonso, N; Ferreira, M; Park, KH; Cortes, J; Tan, AR; Blum, JL; Eaton, L; Gause, CK; Wang, Z; Im, E; Mauro, DJ; Jones, MB; Denker, A; Baselga, J (2017) A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer BREAST CANCER RESEARCH AND TREATMENT 165(3):601-609 IF₂₀₁₆=3.626 [Article]
• Rummel, M; Kim, TM; Aversa, F; Brugger, W; Capochiani, E; Plenteda, C; Re, F; Trask, P; Osborne, S; Smith, R; Grigg, A (2017)  Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20_ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab) ANNALS OF ONCOLOGY 28( 4):836-842 IF₂₀₁₆=11.855 [Article]
• Salpini, R; Surdo, M; Warner, N; Cortese, MF; Colledge, D; Soppe, S; Bellocchi, MC; Armenia, D; Carioti, L; Continenza, F; Di Carlo, D; Saccomandi, P; Mirabelli, C; Pollicita, M; Longo, R; Romano, S; Cappiello, G; Spano, A; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Bertoli, A; Mari, T; Pasquazzi, C; Missale, G; Sarrecchia, C; Orecchini, E; Michienzi, A; Andreoni, M; Francioso, S; Angelico, M; Verheyen, J; Ceccherini-Silberstein, F; Locarnini, S; Perno, CF; Svicher, V (2017)  Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro ONCOTARGET 8( 9):15704-15715 IF₂₀₁₆=5.168 [Article]
• Santini, D; Ratta, R; Pantano, F; De Lisi, D; Maruzzo, M; Galli, L; Biasco, E; Farnesi, A; Buti, S; Sternberg, CN; Cerbone, L; Di Lorenzo, G; Spoto, S; Sterpi, M; De Giorgi, U; Berardi, R; Torniai, M; Camerini, A; Massari, F; Procopio, G; Tonini, G (2017) Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis ONCOTARGET 8(59):100708-100716 IF₂₀₁₆=5.168 [Article]
• Tiseo, M; Boni, L; Ambrosio, F; Camerini, A; Baldini, E; Cinieri, S; Brighenti, M; Zanelli, F; Defraia, E; Chiari, R; Dazzi, C; Tibaldi, C; Turolla, GM; D’Alessandro, V; Zilembo, N; Trolese, AR; Grossi, F; Riccardi, F; Ardizzoni, A (2017)  Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial JOURNAL OF CLINICAL ONCOLOGY 35( 12):1281-+ IF₂₀₁₆=24.008 [Article]
• Tiseo, M; Damato, A; Longo, L; Barbieri, F; Bertolini, F; Stefani, A; Migaldi, M; Gnetti, L; Camisa, R; Bordi, P; Buti, S; Rossi, G (2017)  Analysis of a panel of druggable gene mutations and of ALK and PD-Ll expression in a series of thymic epithelial tumors (TETs) LUNG CANCER 104( ):24-30 IF₂₀₁₆=4.294 [Article]
• Tursi, A; Elisei, W; Picchio, M; Nasi, G; Mastromatteo, AM; Di Mario, F; Di Rosa, E; Brandimarte, MA; Brandimarte, G (2017) Impact of diverticular inflammation and complication assessment classification on the burden of medical therapies in preventing diverticular disease complications in Italy ANNALS OF TRANSLATIONAL MEDICINE 5(16):- IF₂₀₁₆=0 [Article]
• Zagonel, V; Franciosi, V; Brunello, A; Biasco, G; Broglia, C; Cattaneo, D; Cavanna, L; Corsi, D; Farina, G; Fioretto, L; Gamucci, T; Lanzetta, G; Magarotto, R; Maltoni, M; Marchetti, P; Massa, E; Mastromauro, C; Melotti, B; Meriggi, F; Nacci, A; Pavese, I; Piva, E; Quirino, M; Roselli, M; Sacco, C; Tonini, G; Trentin, L; Ucci, G; Labianca, R; Gori, S; Pinto, C; Cascinu, S (2017)  Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) TUMORI 103( 1):9-14 IF₂₀₁₆=1.233 [Review]

2016

• Amadori, S; Suciu, S; Selleslag, D; Aversa, F; Gaidano, G; Musso, M; Annino, L; Venditti, A; Voso, MT; Mazzone, C; Magro, D; De Fabritiis, P; Muus, P; Alimena, G; Mancini, M; Hagemeijer, A; Paoloni, F; Vignetti, M; Fazi, P; Meert, L; Ramadan, SM; Willemze R; de Witte, T; Baron, F (2016) Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial JOURNAL OF CLINICAL ONCOLOGY 34(9):972-+ IF₂₀₁₅=20.982 [Article]
• Ardizzoni, A; Tiseo, M; Boni, L; Di Maio, M; Buffoni, L; Belvedere, O; Grossi, F; D’Alessandro, V; de Marinis, F; Barbera, S; Caroti, C; Favaretto, A; Cortinovis, D; Monica, B; Tixi, L; Ceschia, T; Parisi, S; Ricardi, U; Grimaldi, A; Loreggian, L; Navarriat, P; Huber, RM; Belani, C; Bruswig, PF; Scagliotti, GV; Scolaro, T (2016) Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC LUNG CANCER 100():30-37 IF₂₀₁₅=3.767  [Article]
• Aristei, C; Carotti, A; Palazzari, E; Amico, L; Ruggeri, L; Perrucci, E; Falcinelli, L; Lancellotta, V; Palumbo, I; Falzetti, F; Aversa, F; Merluzzi, M; Velardi, A; Martelli, MF (2016) The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell-Depleted Hematopoietic Stem Cell Transplantation INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96(4):832-839 IF₂₀₁₅=4.495  [Article]
• Bordi, P; Tiseo, M; Baldari, G; Buti, S (2016) Metabolic complete response with vinflunine as second-line therapy in a kidney-transplanted patient with advanced urothelial carcinoma: a case report BMC CANCER 16():- IF₂₀₁₅=3.265  [Article]
• Breccia, M; Stagno, F; Luciano, L; Abruzzese, E; Annunziata, M; D’Adda, M; Maggi, A; Sgherza, N; Russo-Rossi, A; Pregno, P; Castagnetti, F; Iurlo, A; Latagliata, R; Cedrone, M; Di Renzo, N; Sora, F; Rege-Cambrin, G; La Nasa, G; Scortechini, AR; Greco, G; Franceschini, L; Sica, S; Bocchia, M; Crugnola, M; Orlandi, E; Guarini, A; Specchia, G; Rosti, G; Saglio, G; Alimena, G (2016) Dasatinib first-line: Multicentric Italian experience outside clinical trials LEUKEMIA RESEARCH 40:24-29 IF₂₀₁₅=2.606 [Article]
• Buti, S; Bersanelli, M (2016) The ‘nivolution’ in renal cell carcinoma: behind the scenes of clinical trials FUTURE ONCOLOGY 12(18):2061-2063 IF₂₀₁₅=2.129  [Editorial Material]
• Buti, S; Bersanelli, M (2016) Non-clear-cell renal carcinoma therapy: handle with care LANCET ONCOLOGY 17(3):270-271  [Editorial Material]
• Buti, S; Ciccarese, C; Iacovelli, R; Bersanelli, M; Scarpelli, M; Lopez-Beltran, A; Cheng, L; Montironi, R; Tortora, G; Massari, F (2016) Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1-kidney cancer FUTURE ONCOLOGY 12(17):1967-1970 IF₂₀₁₅=2.129  [Article]
• Buti, S; Ciccarese, C; Iacovelli, R; Bersanelli, M; Scarpelli, M; Lopez-Beltran, A; Cheng, L; Montironi, R; Tortora, G; Massari, F (2016) Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2-prostate and bladder cancer FUTURE ONCOLOGY 12(17):1971-1974 IF₂₀₁₅=2.129  [Article]
• Cappuzzo, F; Morabito, A; Normanno, N; Bidoli, P; Del Conte, A; Giannetta, L; Montanino, A; Mazzoni, F; Buosi, R; Burgio, MA; Cerea, G; Chiari, R; Cortinovis, D; Finocchiaro, G; Foltran, L; Migliorino, MR; Tiseo, M; Ferrari, S; De Marinis, F (2016) Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer LUNG CANCER 99():31-37 IF₂₀₁₅=3.767  [Article]
• Cariani, E; Pilli, M; Barili, V; Porro, E; Biasini, E; Olivani, A; Dalla Valle, R; Trenti, T; Ferrari, C; Missale, G (2016) Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments ONCOIMMUNOLOGY 5(8):- IF₂₀₁₅=7.644  [Article]
• Ciccarese, C; Santoni, M; Brunelli, M; Buti, S; Modena, A; Nabissi, M; Artibani, W; Martignoni, G; Montironi, R; Tortora, G; Massari, F (2016) AR-V7 and prostate cancer: The watershed for treatment selection? CANCER TREATMENT REVIEWS 43:27-35 IF₂₀₁₅=7.983 [Review]
• Coccolini, F; Catena, F; Glehen, O; Yonemura, Y; Sugarbaker, PH; Piso, P; Ceresoli, M; Montori, G; Ansaloni, L (2016) Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis EJSO 42(9):1261-1267 IF₂₀₁₅=2.94  [Review]
• Costi, R; Santi, C; Bottarelli, L; Azzoni, C; Le Bian, AZ; Ricco’, M; Sarli, L; Silini, EM; Violi, V (2016) Anastomotic Recurrence of Colon Cancer: Genetic Analysis Challenges the Widely Held Theories of Cancerous Cells’ Intraluminal Implantation and Metachronous Carcinogenesis JOURNAL OF SURGICAL ONCOLOGY 114(2):228-236 IF₂₀₁₅=3.151  [Article]
• Palma, BD; Guasco, D; Pedrazzoni, M; Bolzoni, M; Accardi, F; Costa, F; Sammarelli, G; Craviotto, L; De Filippo, M; Ruffini, L; Omede, P; Ria, R; Aversa, F; Giuliani, N (2016) Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 LEUKEMIA 30(2):409-416 IF₂₀₁₅=12.104 [Article]
• D’Haese, JG; Neumann, J; Weniger, M; Pratschke, S; Bjornsson, B; Ardiles, V; Chapman, W; Hernandez-Alejandro, R; Soubrane, O; Robles-Campos, R; Stojanovic, M; Dalla Valle, R; Chan, ACY; Coenen, M; Guba, M; Werner, J; Schadde, E; Angele, MK (2016) Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC? ANNALS OF SURGICAL ONCOLOGY 23(4):1335-1343 IF₂₀₁₅=3.655 [Article]
• Facchinetti, F; Marabelle, A; Rossi, G; Soria, JC; Besse, B; Tiseo, M (2016) Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC JOURNAL OF THORACIC ONCOLOGY 11(11):1819-1836 IF₂₀₁₅=5.04  [Review]
• Fanotto, V; Ongaro, E; Rihawi, K; Avallone, A; Silvestris, N; Fornaro, L; Vasile, E; Antonuzzo, L; Leone, F; Rosati, G; Giuliani, F; Bordonaro, R; Scartozzi, M; De Maglio, G; Negri, FV; Fasola, G; Aprile, G (2016) HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives ONCOTARGET 7(42):69060-69074 IF₂₀₁₅=5.008  [Review]
• Franceschi, E; Depenni, R; Paccapelo, A; Ermani, M; Faedi, M; Sturiale, C; Michiara, M; Servadei, F; Pavesi, G; Urbini, B; Pisanello, A; Crisi, G; Cavallo, MA; Dazzi, C; Biasini, C; Bertolini, F; Mucciarini, C; Pasini, G; Baruzzi, A; Brandes, AA (2016) Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study JOURNAL OF NEURO-ONCOLOGY 128(1):157-162 IF₂₀₁₅=2.754 [Article]
• Gardini, AC; Scarpi, E; Faloppi, L; Scartozzi, M; Silvestris, N; Santini, D; de Stefano, G; Marisi, G; Negri, FV; Foschi, FG; Valgiusti, M; Ercolani, G; Frassineti, GL (2016) Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib ONCOTARGET 7(41):67142-67149 IF₂₀₁₅=5.008  [Article]
• Gardini, AC; Tenti, E; Masini, C; Nanni, O; Scarpi, E; Valgiusti, M; Restuccia, S; Gallani, ML; Palazzini, S; Bianchini, E; Menozzi, S; Maugeri, A; Amadori, D; Minguzzi, M; Frassineti, GL (2016) Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions ONCOTARGET 7(26):40719-40724 IF₂₀₁₅=5.008 [Article]
• Gentili, M; Clerico, M; Spizzichino, M; Fanelli, G (2016) Use of a checklist to improve pain control in hospitalized cancer patients: the 38Checkpain project FUTURE ONCOLOGY 12(2):199-205 IF₂₀₁₅=2.129 [Article]
• Giampieri, R; Caporale, M; Pietrantonio, F; De Braud, F; Negri, FV; Giuliani, F; Pusceddu, V; Demurtas, L; Restivo, A; Fontanella, C; Aprile, G; Cascinu, S; Scartozzi, M (2016) Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded? CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 100:99-106 IF₂₀₁₅=5.039 [Review]
• Giordano, G; D’Adda, T; Varotti, E; Crovini, G; Silini, EM (2016) Primary alveolar soft part sarcoma of uterine corpus: a case report with immunohistochemical, ultrastructural study and review of literature WORLD JOURNAL OF SURGICAL ONCOLOGY 14:- IF₂₀₁₅=1.286 [Review]
• Giordano, G; Manuguerra, R; Varotti, E; Brigati, F (2016) A case of placental site nodule associated with cervical high-grade squamous intraepithelial lesion EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 37(2):259-261 IF₂₀₁₅=0.58 [Article]
• Gizzo, S; Patrelli, TS; Dall’Asta, A; Di Gangi, S; Giordano, G; Migliavacca, C; Monica, M; Merisio, C; Nardelli, GB; Quaranta, M; Noventa, M; Berretta, R (2016) Coexistence of adenomyosis and endometrioid endometrial cancer: Role in surgical guidance and prognosis estimation ONCOLOGY LETTERS 11(2):1213-1219 IF₂₀₁₅=1.482 [Article]
• La Monica, S; Madeddu, D; Tiseo, M; Vivo, V; Galetti, M; Cretella, D; Bonelli, M; Fumarola, C; Cavazzoni, A; Falco, A; Gervasi, A; Lagrasta, CA; Naldi, N; Barocelli, E; Ardizzoni, A; Quaini, F; Petronini, PG; Alfieri, R (2016) Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation JOURNAL OF THORACIC ONCOLOGY 11(7):1051-1063 IF₂₀₁₅=5.04  [Article]
• Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Guarini, A; Fava, C; Gozzini, A; Bonifacio, M; Sora, F; Crescenzi, SL; Bocchia, M; Crugnola, M; Castagnetti, F; Capodanno, I; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Rizzo, M; Antolino (2016) Frontline Dasatinib Treatment in a “Real-Life” Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia NEOPLASIA 18(9):536-540 IF₂₀₁₅=4.509  [Article]
• Le Bian, AZ; Cesaretti, M; Smadja, C; Costi, R (2016) Total laparoscopic right colectomy: The duodenal window first approach SURGICAL ONCOLOGY-OXFORD 25(2):117-118 IF₂₀₁₅=3.514 [Review]
• Leonetti, A; Bersanelli, M; Castagneto, B; Masini, C; Di Meglio, G; Pellegrino, B; Buti, S (2016) Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review CLINICAL GENITOURINARY CANCER 14(4):277-283 IF₂₀₁₅=2.599  [Review]
• Lippi, G; Mattiuzzi, C; Cervellin, G (2016) Meat consumption and cancer risk: a critical review of published meta-analyses CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 97:1-14 IF₂₀₁₅=5.039 [Review]
• Maines, F; Caffo, O; De Giorgi, U; Fratino, L; Lo Re, G; Zagonel, V; D’Angelo, A; Donini, M; Verderame, F; Ratta, R; Procopio, G; Campadelli, E; Massari, F; Gasparro, D; Ermacora, P; Messina, C; Giordano, M; Alesini, D; Basso, U; Fraccon, AP; Vicario, G; Conteduca, V; Galligioni, E (2016) Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme CLINICAL GENITOURINARY CANCER 14(1):48-55 IF₂₀₁₅=2.599 [Article]
• Massimino, M; Miceli, R; Giangaspero, F; Boschetti, L; Modena, P; Antonelli, M; Ferroli, P; Bertin, D; Pecori, E; Valentini, L; Biassoni, V; GarrS, ML; Schiavello, E; Sardi, I; Cama, A; Viscardi, E; Scarzello, G; Scoccianti, S; Mascarin, M; Quaglietta, L; Cinalli, G; Diletto, B; Genitori, L; Peretta, P; Mussano, A; Buccoliero, A; Calareso, G; Barra, S; Mastronuzzi, A; Giussani, C; Marras, CE; Balter, R; Bertolini, P; Giombelli, E; La Spina, M; Buttarelli, FR; Pollo, B; Gandola, L (2016) Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma NEURO-ONCOLOGY 18(10):1451-1460 IF₂₀₁₅=7.371  [Article]
• Mautone, D; Dall’Asta, A; Monica, M; Galli, L; Capozzi, VA; Marchesi, F; Giordano, G; Berretta, R (2016) Isolated port-site metastasis after surgical staging for low-risk endometrioid endometrial cancer: A case report ONCOLOGY LETTERS 12(1):281-284 IF₂₀₁₅=1.482  [Article]
• Mengoli, MC; Barbieri, F; Bertolini, F; Tiseo, M; Rossi, G (2016) K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literature LUNG CANCER 93:55-58 IF₂₀₁₅=3.767 [Review]
• Mengoli, MC; Bertolini, F; Tiseo, M; Barbieri, F; Fiorentino, M; Ardizzoni, A; Rossi, G (2016) MET DNA Alterations in NSCLC-Letter CLINICAL CANCER RESEARCH 22(14):3697-3698 IF₂₀₁₅=8.738  [Letter]
• Mergoni, G; Vescovi, P; Sala, R; Merigo, E; Passerini, P; Maestri, R; Corradi, D; Govoni, P; Nammour, S; Bianchi, MG (2016) The effect of laser therapy on the expression of osteocalcin and osteopontin after tooth extraction in rats treated with zoledronate and dexamethasone SUPPORTIVE CARE IN CANCER 24(2):807-813 IF₂₀₁₅=2.535 [Article]
• Musolino, A; Boggiani, D; Sikokis, A; Rimanti, A; Pellegrino, B; Vattiato, R; Sgargi, P; Falcini, F; Caminiti, C; Michiara, M; Leonardi, F (2016) Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers CANCER TREATMENT REVIEWS 43:1-7 IF₂₀₁₅=7.983 [Review]
• Negri, FV; Boggiani, D; Rimanti, A; Musolino, A (2016) FCGR, Cetuximab, and Colorectal Cancer Survival-Letter CLINICAL CANCER RESEARCH 22(19):4958-4958 IF₂₀₁₅=8.738  [Letter]
• Novello, S; Pinto, C; Torri, V; Porcu, L; Di Maio, M; Tiseo, M; Ceresoli, G; Magnani, C; Silvestri, S; Veltri, A; Papotti, M; Rossi, G; Ricardi, U; Trodella, L; Rea, F; Facciolo, F; Granieri, A; Zagonel, V; Scagliotti, G (2016) The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 104():9-20 IF₂₀₁₅=5.039  [Review]
• Passalacqua, R; Annunziata, MA; Borreani, C; Diodati, F; Isa, L; Saleri, J; Verusio, C; Caminiti, C (2016) Feasibility of a quality improvement strategy integrating psychosocial care into 28 medical cancer centers (HuCare project) SUPPORTIVE CARE IN CANCER 24(1):147-155 IF₂₀₁₅=2.535 [Article]
• Pastorino, U; Boffi, R; Marchiano, A; Sestini, S; Munarini, E; Calareso, G; Boeri, M; Pelosi, G; Sozzi, G; Silva, M; Sverzellati, N; Galeone, C; La Vecchia, C; Ghirardi, A; Corrao, G (2016) Stopping Smoking Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants JOURNAL OF THORACIC ONCOLOGY 11(5):693-699 IF₂₀₁₅=5.04 [Article]
• Pinto, C; Bella, MA; Capoluongo, E; Carrera, P; Clemente, C; Colombo, N; Cortesi, L; De Rosa, G; Fenizia, F; Genuardi, M; Gori, S; Guarneri, V; Marchetti, A; Marchetti, P; Normanno, N; Pasini, B; Pignata, S; Radice, P; Ricevuto, E; Russo, A; Tagliaferri, P; Tassone, P; Truini, M; Varesco, L (2016) Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients FUTURE ONCOLOGY 12(18):2071-2075 IF₂₀₁₅=2.129  [Editorial Material]
• Ponti, G; Pellacani, G; Martorana, D; Mandel, VD; Loschi, P; Pollio, A; Pecchi, A; Dealis, C; Seidenari, S; Tomasi, A (2016) Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report ONCOLOGY LETTERS 11(6):3709-3714 IF₂₀₁₅=1.482 [Article]
• Rossi, S; Sbaraglia, M; Dell’Orto, MC; Gasparotto, D; Cacciatore, M; Boscato, E; Carraro, V; Toffolatti, L; Gallina, G; Niero, M; Pilozzi, E; Mandolesi, A; Sessa, F; Sonzogni, A; Mancini, C; Mazzoleni, G; Romeo, S; Maestro, R; Tos, APD (2016) Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors ONCOTARGET 7(21):30109-30118 IF₂₀₁₅=5.008 [Article]
• Santini, D; Santoni, M; Conti, A; Procopio, G; Verzoni, E; Galli, L; di Lorenzo, G; De Giorgi, U; De Lisi, D; Nicodemo, M; Maruzzo, M; Massari, F; Buti, S; Altobelli, E; Biasco, E; Ricotta, R; Porta, C; Vincenzi, B; Papalia, R; Marchetti, P; Burattini, L; Berardi, R; Muto, G; Montironi, R; Cascinu, S; Tonini, G (2016) Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma ONCOTARGET 7(22):33381-33390 IF₂₀₁₅=5.008 [Article]
• Sianesi, M; Bertocchi, E; Rossini, M; Del Rio, P; Viani, L (2016) Ovarian metastases from colorectal cancer: prognostic role of prophylactic oophorectomy. A single center experience EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 37(6):792-795 IF₂₀₁₅=0.58  [Article]
• Silva, M; Galeone, C; Sverzellati, N; Marchiano, A; Calareso, G; Sestini, S; La Vecchia, C; Sozzi, G; Pelosi, G; Pastorino, U (2016) Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer JOURNAL OF THORACIC ONCOLOGY 11(2):187-193 IF₂₀₁₅=5.04 [Article]
• Soverini, S; De Benedittis, C; Polakova, KM; Linhartova, J; Castagnetti, F; Gugliotta, G; Papayannidis, C; Mancini, M; Klamova, H; Salvucci, M; Crugnola, M; Iurlo, A; Albano, F; Russo, D; Rosti, G; Cavo, M; Baccarani, M; Martinelli, G (2016) Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients ONCOTARGET 7(16):21982-21990 IF₂₀₁₅=5.008 [Article]
• Storti, P; Marchica, V; Airoldi, I; Donofrio, G; Fiorini, E; Ferri, V; Guasco, D; Todoerti, K; Silbermann, R; Anderson, JL; Zhao, W; Agnelli, L; Bolzoni, M; Martella, E; Mancini, C; Campanini, N; Noonan, DM; Petronini, PG; Neri, A; Aversa, F; Roodman, GD; Giuliani, N (2016) Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo LEUKEMIA 30(12):2351-2363 IF₂₀₁₅=12.104  [Article]
• Uccella, S; Bonzini, M; Palomba, S; Fanfani, F; Malzoni, M; Ceccaroni, M; Seracchioli, R; Ferrero, A; Berretta, R; Vizza, E; Sturla, D; Roviglione, G; Monterossi, G; Casadio, P; Volpi, E; Mautone, D; Corrado, G; Bruni, F; Scambia, G; Ghezzi, F (2016) Laparoscopic vs. open treatment of endometrial cancer in the elderly and very elderly: An age-stratified multicenter study on 1606 women GYNECOLOGIC ONCOLOGY 141(2):211-217 IF₂₀₁₅=4.198 [Article]
• Vavala, T; Follador, A; Tiseo, M; Galetta, D; Morabito, A; Di Maio, M; Martelli, O; Caffo, O; Piovano, PL; Cortinovis, D; Zilembo, N; Casartelli, C; Banna, GL; Ardizzoia, A; Barzelloni, ML; Bearz, A; Genestreti, G; Mucciarini, C; Filipazzi, V; Menis, J; Rizzo, E; Barbieri, F; Rijavec, E; Cecere, F; Bria, E; Spitaleri, G; Rossi, A; Novello, S (2016) BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR-positive non small cell lung cancer patients Results from a multicenter Italian observational study LUNG CANCER 95:73-81 IF₂₀₁₅=3.767 [Article]

2015

• Candoni, A; Aversa, F; Busca, A; Cesaro, S; Girmenia, C; Luppi, M; Rossi, G; Venditti, A; Nosari, AM; Pagano, L (2015) Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data  JOURNAL OF CHEMOTHERAPY 27(1):112 IF₂₀₁₄=1.604[Review]
• Tiseo, M; Bersanelli, M; Perrone, F; Tamborini, E; Settanni, G; Busico, A; Rossi, G; Ardizzoni, A; Pelosi, G (2015) Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patientLUNG CANCER 87(2):204-206 IF₂₀₁₄=3.958 [Article]
• Tiseo, M; Boni, L; Ambrosio, F; Camerini, A; Vitale, MG; Baldini, E; Cinieri, S; Zanelli, F; Defraia, E; Passalacqua, R; Crino, L; Dazzi, C; Tibaldi, C; Turolla, GM; D’Alessandro, V; Zilembo, N; Riccardi, F; Ardizzoni, A (2015) Italian Multicenter Phase III Randomized Study of Cisplatin-Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM TrialCLINICAL LUNG CANCER 16(1):67-70  [Editorial Material]
• Sanchis-Gomar, F; Lucia, A; Yvert, T; Ruiz-Casado, A; Pareja-Galeano, H; Santos-Lozano, A; Fiuza-Luces, C; Garatachea, N; Lippi, G; Bouchard, C; Berger, NA (2015) Physical Inactivity and Low Fitness Deserve More Attention to Alter Cancer Risk and PrognosisCANCER PREVENTION RESEARCH 8(2):105-110 IF₂₀₁₄=4.444 [Article]
• Galli, D; Carubbi, C; Masselli, E; Corradi, D; Dei Cas, A; Nouvenne, A; Bucci, G; Arcari, ML; Mirandola, P; Vitale, M; Gobbi, G (2015) PKC epsilon is a negative regulator of PVAT-derived vessel formationEXPERIMENTAL CELL RESEARCH 330(2):277-286 IF₂₀₁₄=3.246 [Article]
• Franceschi, E; Ermani, M; Bartolini, S; Bartolotti, M; Poggi, R; Tallini, G; Marucci, G; Fioravanti, A; Tosoni, A; Agati, R; Bacci, A; Pozzati, E; Morandi, L; Balestrini, D; Ghimenton, C; Crisi, G; Brandes, AA (2015) Post progression survival in glioblastoma: where are we?JOURNAL OF NEURO-ONCOLOGY 121(2):399-404 IF₂₀₁₄=3.070[Article]
• Buti, S; Ciccarese, C; Zanoni, D; Santoni, M; Modena, A; Maines, F; Gilli, A; Bria, E; Brunelli, M; Rimanti, A; Cascinu, S; Ardizzoni, A; Tortora, G; Massari, F (2015) Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand? FUTURE ONCOLOGY 11(1):107-119 IF₂₀₁₄=2.477[Review]
• Sternberg, CN; Calabro, F; Bracarda, S; Carteni, G; Lo Re, G; Ruggeri, EM; Basso, U; Gasparini, G; Ciuffreda, L; Ferrari, V; Bonetti, A; Fea, E; Gasparro, D; Tassinari, D; Labianca, R; Masini, C; Fly, K; Zhang, K; Hariharan, S; Capaccetti, B; Porta, C (2015) Safety and Efficacy of Sunitinib in Patients from Italy with Metastatic Renal Cell Carcinoma: Final Results from an Expanded-Access Trial ONCOLOGY 88(5):273-280 IF₂₀₁₄=2.613 [Article]
• Tralongo, P; Dal Maso, L; Surbone, A; Santoro, A; Tirelli, U; Sacchini, V; Pinto, C; Crispino, S; Ferrau, F; Mandoliti, G; Tonini, G; Russo, A; Santini, D; Madeddu, A; Panebianco, V; Pergolizzi, S; Respini, D; Rolfo, C; Bongiovanni, M; De Lorenzo, F; Spatola, C; Di Raimondo, F; Terenziani, M; Peeters, M; Castoro, C (2015) Use of the word “cured” for cancer patients-implications for patients and physicians: the Siracusa charter CURRENT ONCOLOGY 22(1):E38-E40 IF₂₀₁₄=1.785 [Article]
• Sieri, S; Krogh, V; Agnoli, C; Ricceri, F; Palli, D; Masala, G; Panico, S; Mattiello, A; Tumino, R; Giurdanella, MC; Brighenti, F; Scazzina, F; Vineis, P; Sacerdote, C (2015)  Dietary glycemic index and glycemic load and risk of colorectal cancer: results from the EPIC-Italy study INTERNATIONAL JOURNAL OF CANCER 136(12):29232931 IF₂₀₁₄ = 5.085 [Article]
• Tiseo, M; Gelsomino, F; Alfieri, R; Cavazzoni, A; Bozzetti, C; De Giorgi, AM; Petronini, PG; Ardizzoni, A (2015)  FGFR as potential target in the treatment of squamous non small cell lung cancer CANCER TREATMENT REVIEWS 41(6):527539 IF₂₀₁₄ = 7.588[Review]
• Palandri, F; Latagliata, R; Polverelli, N; Tieghi, A; Crugnola, M; Martino, B; Perricone, M; Breccia, M; Ottaviani, E; Testoni, N; Merli, F; Aversa, F; Alimena, G; Cavo, M; Martinelli, G; Catani, L; Baccarani, M; Vianelli, N (2015)  Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis LEUKEMIA 29(6):13441349 IF₂₀₁₄ = 10.431 [Article]
• Buti, S ;Bordi, P ; Tiseo, M ; Bria, E ; Sperduti, I; Di Maio, M; Panni, S; Novello, S; Rapetti, SG; Pilotto, S; Genestreti, G; Rossi, A; Pezzuolo, D; Camisa, R ; Tortora, G; Ardizzoni, A (2015)  Predictive role of erythrocyte rnacrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients LUNG CANCER 88(3):319324 IF₂₀₁₄ = 3.958 [Article]
• Brandes, AA; Bartlotti, M; Marucci, G; Ghimenton, C; Agati, R; Fioravanti, A; Mascarin, M; Volpin, L; Ammannati, F; Masotto, B; Gardiman, MP; De Biase, D; Tallini, G;Crisi, G ; Bartolini, S; Franceschi, E (2015)  New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 94(3):348359 IF₂₀₁₄ = 4.027 [Review]
• Santoni, M; Conti, A; Partelli, S; Porta, C; Sternberg, CN; Procopio, G; Bracarda, S; Basso, U; De Giorgi, U; Derosa, L; Rizzo, M; Ortega, C; Massari, F; Iacovelli, R; Milella, M; Di Lorenzo, G;Buti, S ; Cerbone, L; Burattini, L; Montironi, R; Santini, D; Falconi, M; Cascinu, S (2015)  Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors ANNALS OF SURGICAL ONCOLOGY 22(6):20942100 IF₂₀₁₄ = 3.930 [Article]
• Fioredda, F; Calvillo, M; Lanciotti, M; Cefalo, MG; Tucci, F; Farruggia, P; Casazza, G; Martire, B; Bonanomi, S; Notarangelo, L;Barone, A ; Palazzi, G; Davitto, M; Barella, S; Cardinale, F; Mastrodicasa, E; Cugno, C; Russo, G; Caviglia, I; Caruso, S; Castagnola, E; Dufour, C (2015)  Lethal Sepsis and Malignant Transformation in Severe Congenital Neutropenia: Report From the Italian Neutropenia Registry PEDIATRIC BLOOD & CANCER 62(6):11101112 IF₂₀₁₄ = 2.384 [Letter]
• Colla, S; Ong, DST; Ogoti, Y;Marchesini, M ; Mistry, NA; Clise-Dwyer, K; Ang, SA; Storti, P; Viale, A; Giuliani, N ; Ruisaard, K; Gomez, IG; Bristow, CA; Estecio, M; Weksberg, DC; Ho, YW; Hu, BL; Genovese, G; Pettazzoni, P; Multani, AS; Jiang, S; Hua, SJ; Ryan, MC; Carugo, A; Nezi, L; Wei, Y; Yang, H; D’Anca, M; Zhang, L; Gaddis, S; Gong, T; Horner, JW; Heffernan, TP; Jones, P; Cooper, LJN; Liang, H; Kantarjian, H; Wang, YA; Chin, L; Bueso-Ramos, C; Garcia-Manero, G; DePinho, RA (2015)  Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome CANCER CELL 27(5):644657 IF₂₀₁₄ = 23.523[Article]
• Farnedi, A; Rossi, S; Bertani, N; Gulli, M;Silini, EM ; Mucignat, MT; Poli, T ;Sesenna, E ; Lanfranco, D; Montebugnoli, L; Leonardi, E; Marchetti, C; Cocchi, R; Ambrosini-Spaltro, A; Foschini, MP; Perris, R (2015)  Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors BMC CANCER 15 IF₂₀₁₄ = 3.362[Article]
• Tiseo, M ; Boni, L; Ardizzoni, A (2015)  Second-line Treatment of Small Cell Lung Cancer Is Platinum Sensitivity a Relevant Prognostic Factor?JOURNAL OF THORACIC ONCOLOGY 10(5):E35E36 IF₂₀₁₄ = 5.282 [Letter]
• Rossi, G; Baldi, L; Barbieri, F; Bertolini, F;Tiseo, M  (2015)  Concomitant EGFR and KRAS mutations in ALK-rearranged lung cancer ANNALS OF ONCOLOGY 26(5):10351036 IF₂₀₁₄ = 7.040 [Letter]
• Amit, M; Na’ara, S; Sharma, K; Ramer, N; Ramer, I; Agbetoba, A; Glick, J; Yang, XJ; Lei, DL; Bjoerndal, K; Godballe, C; Mucke, T; Klaus-Dietrich, W; Eckardt, AM; Copelli, C;Sesenna, E ; Palmer, F; Ganly, I; Gil, Z (2015)  Elective Neck Dissection in Patients With Head and Neck Adenoid Cystic Carcinoma: An International Collaborative StudyANNALS OF SURGICAL ONCOLOGY 22(4):13531359 IF₂₀₁₄ = 3.930 [Article]
• Del Rio, P ;Maestroni, U ; Sianesi, M ; Viani, L; Vicente, D; Stojadinovic, A; Avital, I (2015)  Minimally invasive video-assisted thyroidectomy for papillary thyroid cancer: a prospective 5-year follow-up study TUMORI 101(2):144147 IF₂₀₁₄ = 1.269 [Article]
• Bordi, P ;Tiseo, M ; Buti, S ; Regolisti, G ; Ardizzoni, A (2015)  Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH TUMORI 101(2):E51E53 IF₂₀₁₄= 1.269 [Article]
• Guarneri, V; Dieci, MV; Frassoldati, A; Maiorana, A; Ficarra, G; Bettelli, S; Tagliafico, E; Bicciato, S; Generali, DG; Cagossi, K; Bisagni, G; Sarti, S;Musolino, A; Ellis, C; Crescenzo, R; Conte, P (2015) Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast CancerONCOLOGIST 20 (9):1001 – 1010 IF₂₀₁₄= 4.865 [Article]   
• Facchinetti, F; Aldigeri, R;Aloe, R; Bortesi, B; Ardizzoni, A; Tiseo, M(2015) CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients TUMOR BIOLOGY 36 (8):5943 – 5951 IF₂₀₁₄ = 3.611 [Article]
• Bonelli, MA; Cavazzoni, A; Saccani, F; Alfieri, RR;Quaini, F; La Monica, S; Galetti, M; Cretella, D; Caffarra, C; Madeddu, D; Frati, C; Lagrasta, CA; Falco, A; Rossetti, P; Fumarola, C; Tiseo, M; Petronini, PG; Ardizzoni, A (2015) Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations MOLECULAR CANCER THERAPEUTICS 14 (8):1916 – 1927 IF₂₀₁₄ = 5.683 [Article]   
• Fusco, V; Porta, C; Saia, G; Paglino, C; Bettini, G; Scoletta, M; Bonacina, R;Vescovi, P; Merigo, E; Lo Re, G; Guglielmini, P; Di Fede, O; Campisi, G; Bedogni, A (2015) Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature CLINICAL GENITOURINARY CANCER 13 (4):287 – 294 IF₂₀₁₄ = 2.322 [Review]  
• Coccolini, F;Catena, F; Glehen, O; Yonemura, Y; Sugarbaker, PH; Piso, P; Montori, G; Ansaloni, L (2015) Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis EJSO 41 (7):911 – 919 IF₂₀₁₄= 3.009 [Article]  
• Berretta, R; Gizzo, S; Noventa, M; Marrazzo, V; Franchi, L; Migliavacca, C; Michela, M;Merisio, C; Modena, AB; Patrelli, TS (2015) Quality of Life in Patients Affected by Endometrial Cancer: Comparison Among Laparotomy, Laparoscopy and Vaginal Approach PATHOLOGY & ONCOLOGY RESEARCH 21 (3):811 – 816 IF₂₀₁₄ = 1.855 [Article]    
• Ganly, I; Amit, M; Kou, L; Palmer, FL; Migliacci, J; Katabi, N; Yu, CH; Kattan, MW; Binenbaum, Y; Sharma, K; Naomi, R; Abib, A; Miles, B; Yang, XJ; Lei, DL; Bjoerndal, K; Godballe, C; Mucke, T; Wolff, KD; Fliss, D; Eckardt, AM; Chiara, C;Sesenna, E; Ali, S; Czerwonka, L; Goldstein, DP; Gil, Z; Patel, SG (2015) Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study EUROPEAN JOURNAL OF CANCER 51 (18):2768 – 2776 IF₂₀₁₄ = 5.417 [Article]   
• Schilling, C; Stoeckli, SJ; Haerle, SK; Broglie, MA; Huber, GF; Sorensen, JA; Bakholdt, V; Krogdahl, A; von Buchwald, C; Bilde, A; Sebbesen, LR; Odell, E; Gurney, B; O’Doherty, M; de Bree, R; Bloemena, E; Flach, GB; Villarreal, PM; Forcelledo, MFF; Gutierrez, LMJ; Amezaga, JA; Barbier, L; Santamaria-Zuazua, J; Moreira, A; Jacome, M; Vigili, MG; Rahimi, S; Tartaglione, G; Lawson, G; Nollevaux, MC; Grandi, C; Donner, D; Bragantini, E; Dequanter, D; Lothaire, P;Poli, T; Silini, EM; Sesenna, E; Dolivet, G; Mastronicola, R; Leroux, A; Sassoon, I; Sloan, P; McGurk, M (2015) Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancerEUROPEAN JOURNAL OF CANCER 51 (18):2777 – 2784 IF₂₀₁₄ = 5.417 [Article]
• Santoni, M;Buti, S; Conti, A; Porta, C; Procopio, G; Sternberg, CN; Bracarda, S; Basso, U; De Giorgi, U; Rizzo, M; Derosa, L; Ortega, C; Massari, F; Milella, M; Bersanelli, M; Cerbone, L; Muzzonigro, G; Burattini, L; Montironi, R; Santini, D; Cascinu, S (2015) Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy TARGETED ONCOLOGY 10 (4):517 – 522 IF₂₀₁₄= 4.0 [Article]   
• Fasola, G; Aprile, G;Pinto, C(2015) Balancing Clinical Progress With Economic Sustainability: In Quest of a Courageous Solution JOURNAL OF CLINICAL ONCOLOGY 33 (32):3841 – 3841 IF₂₀₁₄ = 18.443 [Letter]    
• Buti, S; Bersanelli, M (2015) Combination therapy in kidney cancer: the next revolution?LANCET ONCOLOGY 16 (15):1441 – 1442 IF₂₀₁₄= 24.69 [Editorial Material]  
• Masselli, E; Carubbi, C; Gobbi, G; Mirandola, P; Galli, D; Martini, S;Bonomini, S;Crugnola, M; Craviotto, L; Aversa, F; Vitale, M (2015) Protein kinase C epsilon inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients LEUKEMIA 29 (11):2192 – 2201 IF₂₀₁₄ = 10.431 [Article]    
• De Marinis, F; Bria, E; Baas, P;Tiseo, M; Camerini, A; Favaretto, AG; Gridelli, C (2015) Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel CLINICAL LUNG CANCER 16 (6):399 – 405 IF₂₀₁₄ = 3.104 [Review]
• Genestreti, G;Tiseo, M; Kenmotsu, H; Kazushige, W; Di Battista, M; Cavallo, G; Carloni, F; Bongiovanni, A; Burgio, MA; Casanova, C; Metro, G; Scarpi, E; Korkmaz, T; Selcuk, S; Roopa, K; Califano, R (2015) Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis CLINICAL LUNG CANCER 16 (6):E223 – E228 IF₂₀₁₄ = 3.104 [Article]    
• Sestini, S; Boeri, M; Marchiano, A; Pelosi, G; Galeone, C; Verri, C; Suatoni, P;Sverzellati, N; La Vecchia, C; Sozzi, G; Pastorino, U (2015) Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningONCOTARGET 6 (32):32868 – 32877 IF₂₀₁₄ = 6.359 [Article]  
• Negri, FV; Porta, C (2015) Urea-Based Cream to Prevent Sorafenib-Induced Hand-and-Foot Skin Reaction: Which Evidence?JOURNAL OF CLINICAL ONCOLOGY 33 (28):3219 – 3219 IF₂₀₁₄ = 18.443 [Letter]  
• Russi, EG; Moretto, F; Rampino, M; Benasso, M; Bacigalupo, A; De Sanctis, V; Numico, G; Bossi, P; Buglione, M; Lombardo, A; Airoldi, M; Merlano, MC; Licitra, L; Denaro, N; Pergolizzi, S;Pinto, C; Bensadoun, RJ; Girolomoni, G; Langendijk, JA (2015) Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 96 (1):167 – 182 IF₂₀₁₄ = 4.027 [Review]
• Breccia, M; Efficace, F; Sica, S; Abruzzese, E; Cedrone, M; Turri, D; Gobbi, M; Carella, AM; Gozzini, A; Usala, E; Cavazzini, F; Danise, P; Tiribelli, M; Binotto, G; Pregno, P; Bocchia, M; Gaidano, G;Crugnola, M; Bonifacio, M; Avanzini, P; Celesti, F; Guella, A; Martino, B; Annunziata, M; Luciano, L; Stagno, F; Vallisa, D; Pungolino, E; Iurlo, A; Rambaldi, A; Nardiello, I; Orlandi, E; Gambacorti-Passerini, C; Alimena, G (2015) Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient- based survey on 1133 patients LEUKEMIA RESEARCH 39 (10):1055 – 1059 IF₂₀₁₄ = 2.351 [Article]